Cargando…
PD-1 independent of PD-L1 ligation promotes glioblastoma growth through the NFκB pathway
Brain tumor–initiating cells (BTICs) drive glioblastoma growth through not fully understood mechanisms. Here, we found that about 8% of cells within the human glioblastoma microenvironment coexpress programmed cell death 1 (PD-1) and BTIC marker. Gain- or loss-of-function studies revealed that tumor...
Autores principales: | Mirzaei, Reza, Gordon, Ashley, Zemp, Franz J., Kumar, Mehul, Sarkar, Susobhan, Luchman, H. Artee, Bellail, Anita C., Hao, Chunhai, Mahoney, Douglas J., Dunn, Jeff F., Bose, Pinaki, Yong, V. Wee |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Association for the Advancement of Science
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8570610/ https://www.ncbi.nlm.nih.gov/pubmed/34739319 http://dx.doi.org/10.1126/sciadv.abh2148 |
Ejemplares similares
-
Fibrinogen in the glioblastoma microenvironment contributes to the invasiveness of brain tumor‐initiating cells
por: Dzikowski, Lauren, et al.
Publicado: (2021) -
PD-L1 methylation restricts PD-L1/PD-1 interactions to control cancer immune surveillance
por: Huang, Changsheng, et al.
Publicado: (2023) -
Functional binding of PD1 ligands predicts response to anti-PD1 treatment in patients with cancer
por: Kaufman, Bar, et al.
Publicado: (2023) -
PD-1/PD-L1 blockade abrogates a dysfunctional innate-adaptive immune axis in critical β-coronavirus disease
por: Duhalde Vega, Maite, et al.
Publicado: (2022) -
Successful targeting of PD-1/PD-L1 with chimeric antigen receptor-natural killer cells and nivolumab in a humanized mouse cancer model
por: Liu, Wai Nam, et al.
Publicado: (2022)